Shatzel, J J <br/><br/>
Ibrutinib-associated bleeding: pathogenesis, management and risk reduction strategies.  [electronic resource] 

 -  Journal of thrombosis and haemostasis : JTH  05 2017 
 - 835-847 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1538-7836 
<br/><br/><label>Standard No.: </label>10.1111/jth.13651  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenine--analogs & derivatives<br/>Animals<br/>Anticoagulants--administration & dosage<br/>Antineoplastic Agents--adverse effects<br/>Blood Coagulation--drug effects<br/>Blood Platelets--drug effects<br/>Drug Interactions<br/>Drug Substitution<br/>Hemorrhage--chemically induced<br/>Humans<br/>Piperidines<br/>Platelet Aggregation Inhibitors--administration & dosage<br/>Protein Kinase Inhibitors--administration & dosage<br/>Pyrazoles--administration & dosage<br/>Pyrimidines--administration & dosage<br/>Risk Assessment<br/>Risk Factors<br/>Signal Transduction--drug effects